5-fluorouracil-loaded mesoporous copper-coated manganese dioxide nanoparticles for synergistic photothermal and chemotherapy in 5-FU-resistant colon cancer
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 14011-14027
DOI: 10.1007/s00210-026-05152-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 08.04.2026. Verfasst von Tingting Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. Hauptthemen laut MEDLINE: Fluorouracil, Colonic Neoplasms, Manganese Compounds, Oxides. Die Arbeit nennt 53 Literaturangaben. Gefördert von: This study was supported by the Wenzhou Science and Technology Bureau Self-Funded Medical Project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Nanoplatforms engineered for targeted delivery are crucial for improving tumor treatment by concentrating chemotherapy in tumors, improving drug solubility/efficacy, enabling personalized therapies, and reducing systemic toxicity. We present a nanoplatform (MCuS/5FU/IG@MnO2@S100A8/A9 (MCFIMS)) that synergistically improves chemodynamic therapy (CDT), photothermal therapy (PTT), photodynamic treatment (PDT), and chemotherapy. The nanoplatform comprises dual-shell MC@M NPs that enable targeted delivery of the chemotherapeutic drug 5-Fluorouracil (5FU) and the photosensitizer indocyanine green (IG). These MCFIMS NPs enhance the chemotherapeutic efficiency of 5FU by effectively using glutathione (GSH). The integration of the colon-targeting peptide (S100A8/A9) enables the nanoplatform to deliver receptor-mediated targeting to colon cancer cells. Significantly, when paired with near-infrared (NIR) light, MCFIMS exhibited an extraordinary tumor proliferation. Overall, this nanoplatform possesses nuclear-targeting ability, facilitating the concentration of chemotherapeutic drugs at tumor sites of proliferation, and shows promise for synergistic applications to augment chemotherapy in 5FU-resistant colon cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
- Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Wenzhou Medical University, South Baixiang Avenue, Ouhai District, Wenzhou, 325000, China.
- Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Wenzhou Medical University, South Baixiang Avenue, Ouhai District, Wenzhou, 325000, China. guanfangnano@outlook.com.
Förderung
- This study was supported by the Wenzhou Science and Technology Bureau Self-Funded Medical Project
Zitieren
APA
Chen, T., Mao, R., & Fang, G. (2026). 5-fluorouracil-loaded mesoporous copper-coated manganese dioxide nanoparticles for synergistic photothermal and chemotherapy in 5-FU-resistant colon cancer. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 14011-14027. https://doi.org/10.1007/s00210-026-05152-9
Vancouver
Chen T, Mao R, Fang G. 5-fluorouracil-loaded mesoporous copper-coated manganese dioxide nanoparticles for synergistic photothermal and chemotherapy in 5-FU-resistant colon cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):14011-14027. doi:10.1007/s00210-026-05152-9
BibTeX
@article{Chen2026,
author = {Chen, Tingting and Mao, Ruibo and Fang, Guan},
title = {5-fluorouracil-loaded mesoporous copper-coated manganese dioxide nanoparticles for synergistic photothermal and chemotherapy in 5-FU-resistant colon cancer},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {14011--14027},
doi = {10.1007/s00210-026-05152-9}
}
EUVIMED